Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital (NKI-AVL)

The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital (NKI-AVL), founded in 1913 and based in Amsterdam, is an independent comprehensive cancer center, comprising a hospital and research laboratories under one roof in a single independent organization.

Their research institute accommodates 750 scientists and scientific support personnel from more than 45 different countries. The Antoni van Leeuwenhoek Hospital has 230 medical specialists, 212 beds, an out-patients clinic with around 140.000 visits annually, 12 operating theaters and 11 irradiation units for radiotherapy.

Their research institute gratefully acknowledges funding from the Ministry of Health, Welfare and Sport, the Dutch Cancer Society and individuals donors, and from project grants from national and international organizations.

Vision:
They have set ourselves a bold goal: a cure for every cancer. This is what they owe all 18 million people worldwide diagnosed with cancer each year. They are ranked among the global top 10 of cancer centers and they simply want to make the world a better and healthier place through our research and patient care.

They cannot reach this goal overnight. It requires brilliant minds, dedicated doctors, wise investments, strategic choices, and stamina.

They know that cutting-edge fundamental and translational research is needed first to get a thorough understanding of the disease and ultimately have patient impact - today’s research for tomorrow’s cure.

At the same time, they want to speed up this process through translational research and optimal synergy between our researchers and our clinicians.

They also cannot reach our ambitious goal on our own. They are one of many global players who have a responsibility to collaborate to tackle the global cancer challenge. This is why knowledge exchange and collaboration at a regional, national, European and global scale are top of the list in our institutional strategy.